These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29357765)

  • 1. Accessible miRNAs as Novel Toxicity Biomarkers.
    Bailey WJ; Glaab WE
    Int J Toxicol; 2018; 37(2):116-120. PubMed ID: 29357765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beagle dog MicroRNA tissue atlas: identifying translatable biomarkers of organ toxicity.
    Koenig EM; Fisher C; Bernard H; Wolenski FS; Gerrein J; Carsillo M; Gallacher M; Tse A; Peters R; Smith A; Meehan A; Tirrell S; Kirby P
    BMC Genomics; 2016 Aug; 17():649. PubMed ID: 27535741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury.
    Laterza OF; Lim L; Garrett-Engele PW; Vlasakova K; Muniappa N; Tanaka WK; Johnson JM; Sina JF; Fare TL; Sistare FD; Glaab WE
    Clin Chem; 2009 Nov; 55(11):1977-83. PubMed ID: 19745058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Rat microRNA body atlas; Evaluation of the microRNA content of rat organs through deep sequencing and characterization of pancreas enriched miRNAs as biomarkers of pancreatic toxicity in the rat and dog.
    Smith A; Calley J; Mathur S; Qian HR; Wu H; Farmen M; Caiment F; Bushel PR; Li J; Fisher C; Kirby P; Koenig E; Hall DG; Watson DE
    BMC Genomics; 2016 Aug; 17(1):694. PubMed ID: 27576563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA Biomarkers of Toxicity in Biological Matrices.
    Harrill AH; McCullough SD; Wood CE; Kahle JJ; Chorley BN
    Toxicol Sci; 2016 Aug; 152(2):264-72. PubMed ID: 27462126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress in the use of microRNAs as biomarkers for drug-induced toxicities in contrast to traditional biomarkers: A comparative review.
    Oda S; Yokoi T
    Drug Metab Pharmacokinet; 2021 Apr; 37():100372. PubMed ID: 33461055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of microRNAs-208 and 133a/b as differential biomarkers of acute cardiac and skeletal muscle toxicity in rats.
    Calvano J; Achanzar W; Murphy B; DiPiero J; Hixson C; Parrula C; Burr H; Mangipudy R; Tirmenstein M
    Toxicol Appl Pharmacol; 2016 Dec; 312():53-60. PubMed ID: 26627004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Promising Urinary MicroRNA Biomarkers in Two Rat Models of Glomerular Injury.
    Nassirpour R; Homer BL; Mathur S; Li Y; Li Z; Brown T; Carraher D; Warneke J; Bailey S; Percival K; O'Neil SP; Whiteley LO
    Toxicol Sci; 2015 Nov; 148(1):35-47. PubMed ID: 26253709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephron segment specific microRNA biomarkers of pre-clinical drug-induced renal toxicity: Opportunities and challenges.
    Nassirpour R; Ramaiah SK; Whiteley LO
    Toxicol Appl Pharmacol; 2016 Dec; 312():34-41. PubMed ID: 26827821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frontiers in preclinical safety biomarkers: microRNAs and messenger RNAs.
    Mikaelian I; Scicchitano M; Mendes O; Thomas RA; Leroy BE
    Toxicol Pathol; 2013 Jan; 41(1):18-31. PubMed ID: 22659243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicological implications of modulation of gene expression by microRNAs.
    Yokoi T; Nakajima M
    Toxicol Sci; 2011 Sep; 123(1):1-14. PubMed ID: 21715665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of circulating microRNAs as clinical biomarkers for cardiovascular diseases.
    Kondkar AA; Abu-Amero KK
    Biomed Res Int; 2015; 2015():821823. PubMed ID: 25710029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
    Duarte FV; Palmeira CM; Rolo AP
    Adv Exp Med Biol; 2015; 888():123-54. PubMed ID: 26663182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer.
    Nedaeinia R; Manian M; Jazayeri MH; Ranjbar M; Salehi R; Sharifi M; Mohaghegh F; Goli M; Jahednia SH; Avan A; Ghayour-Mobarhan M
    Cancer Gene Ther; 2017 Feb; 24(2):48-56. PubMed ID: 27982021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs as potential biomarkers in cancer: opportunities and challenges.
    Lan H; Lu H; Wang X; Jin H
    Biomed Res Int; 2015; 2015():125094. PubMed ID: 25874201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ins and outs of microRNAs as biomarkers in liver disease and transplantation.
    Farid WR; Verhoeven CJ; de Jonge J; Metselaar HJ; Kazemier G; van der Laan LJ
    Transpl Int; 2014 Dec; 27(12):1222-32. PubMed ID: 24963540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel equine tissue miRNAs and breed-related miRNA expressed in serum.
    Pacholewska A; Mach N; Mata X; Vaiman A; Schibler L; Barrey E; Gerber V
    BMC Genomics; 2016 Oct; 17(1):831. PubMed ID: 27782799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNAs and their application in drug-induced liver injury.
    Wang Y; Chen T; Tong W
    Biomark Med; 2014; 8(2):161-72. PubMed ID: 24521012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases.
    Weiland M; Gao XH; Zhou L; Mi QS
    RNA Biol; 2012 Jun; 9(6):850-9. PubMed ID: 22699556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulated microRNAs involved in contrast-induced acute kidney injury in rat and human.
    Gutiérrez-Escolano A; Santacruz-Vázquez E; Gómez-Pérez F
    Ren Fail; 2015; 37(9):1498-506. PubMed ID: 26337190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.